Centivax Raises $37M in Funding led by Structure Fund to expand operations and development efforts of its universal flu vaccine.
Amount Raised
$37 Million
Round Type
Funding Round
South San FranciscoBiotechnologyHealth CareInvestors
Description
Centivax, a South San Francisco biotechnology company, raised $37 million in a funding round led by Structure Fund. The funds will be used to expand operations and development efforts for its universal flu vaccine. The round saw participation from various investors including Meiji Seika Pharma Co. and Stripe founders
Quick answer
Centivax raised $37 Million in a Funding Round round, dated March 30, 2026. Investors: Meiji Seika Pharma Co., Sigmas Group, Kendall Capital Partners, Patrick Collison, John Collison and Structure Fund. Centivax is based in South San Francisco, California, United States.
- How much did Centivax raise?
- Centivax raised $37 Million in a Funding Round round on March 30, 2026.
- Who invested in Centivax?
- Meiji Seika Pharma Co., Sigmas Group, Kendall Capital Partners, Patrick Collison, John Collison and Structure Fund are named as investors in this round.
- What does Centivax do?
- Centivax is a South San Francisco-based biotechnology company founded in 2020, focused on advancing global health through broad-spectrum vaccines and antivenoms.
- Where is Centivax based and how big is it?
- Centivax is based in South San Francisco, California, United States. Fundz records about 27 employees.
- Who are the decision-makers at Centivax?
- Fundz holds 1 contact at Centivax, including the Chief Science Officer (CSO)-Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Centivax that raised within 45 days of this round, from Fundz verified event records.
- Ollin Biosciences raised $330M (Series B) on May 14, 2026.
- Butterfly Medical Ltd raised $21M (Series C) on May 14, 2026.
- CREATE Medicines raised $122M (Series B) on May 14, 2026.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
- Envoke raised $2.1M (Seed) on May 14, 2026.
- UroMems raised $60M (Funding Round) on May 13, 2026.
Who to call at Centivax, and when
A new round usually means Centivax is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Centivax raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Centivax, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Centivax. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Centivax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Centivax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.